Efficacy of serum anti-mullerian hormone (AMH) levels for prediction of polycystic ovary syndrome (PCOS) and its association with clinical, biochemical and hormonal parameters
- 6 September 2022
- journal article
- research article
- Published by Springer Nature in Indian Journal of Clinical Biochemistry
- Vol. 38 (4) , 457-465
Abstract
Anti-mullerian hormone (AMH) has been proposed to add significance to diagnosis of PCOS in case of ambiguity. However, variable cutoffs of AHM among PCOS women have been reported. Using case-control design, this study investigated the diagnostic threshold of serum AMH levels among age matched 113 PCOS and 75 normo-ovulatory women and its correlation with clinical, hormonal and ultrasonographic parameters.PCOS was defined as per Rotterdam criteria 2003. Results depicted the mean serum AMH level to be significantly higher in PCOS group (7.84 ± 3.67vs. 3.23 ± 1.56 ng/mL) than controls. The AMH levels were positively(p = 0.001) associated with ovarian volume (r = 0.521) as well as number of ovarian follicles(r = 0.461). Further, serum AMH levels showed a positive correlation with luteinizing hormone/follicle stimulating hormone (LH/FSH) ratio (r = 0.206, p = 0.02), but no correlation significant with age, BMI,FG score and testosterone levels. As per receiver operating characteristic (ROC) curve, cut-off was worked out to be 3.76 ng/ml with 86.7% sensitivity and 62.7% specificity. The mean level of AMH were highest among PCOS women with phenotype A (12.67 ± 3.46 ng/ml) with least among PCOS women displaying phenotype B(7.28 ± 1.60 ng/ml) where there is absence of PCOM. In conclusion, serum AMH levels are highly predictive of PCOM and high LH/FSH ratio among PCOS women and may be a potent diagnostic marker of ovarian dysfunction either alone or in conjunction with other tools.Keywords
This publication has 29 references indexed in Scilit:
- Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced?Human Reproduction, 2012
- Anti-Mullerian hormone serum level as a predictive marker of ovarian function in Taiwanese womenJournal of the Chinese Medical Association, 2012
- Differences of the association of anti-Müllerian hormone with clinical or biochemical characteristics between women with and without polycystic ovary syndromeEndocrine Journal, 2012
- Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovariesHuman Reproduction, 2011
- Evaluation of serum antimullerian hormone and inhibin B concentrations in the differential diagnosis of secondary oligoamenorrheaFertility and Sterility, 2011
- Polycystic ovarian morphology in adolescents with regular menstrual cycles is associated with elevated anti-Mullerian hormoneHuman Reproduction, 2011
- Antimüllerian hormone and polycystic ovary syndromeFertility and Sterility, 2011
- Elevated serum anti-mullerian hormone in adolescent and young adult Chinese patients with polycystic ovary syndromeWiener klinische Wochenschrift, 2010
- Serum antimullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS)Fertility and Sterility, 2010
- Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese womenFertility and Sterility, 2009